Skip to content
OncoPharm cover art

All episodes

OncoPharm, 449 episodes. Page 3 of 5.

#
Title
201

9 22

202

ESMO 2022 - NICHE-2 and Codebreak 200

203

Biliary Tract Cancer & Pemigatinib (unrelated) Updates

204

Temozolomide + RT For GBM

205

All About Asparaginase

206

HER2 Mutated NSCLC

207

Updated Adjuvant Atezolizumab Data (& more)

208

The Infamous Erlotinib Study

209

Long Term Follow-Up

210

Living With Lupus

211

ICIs & PPIs - Something to Worry About?

212

APAP + ICI: An emerging concern?

213

FN Updates

214

LGBTQ Clinical Pearls

215

ASCO 2022 Highlights

216

Transgender Cancer Screening

217

What's Next In NSCLC & AML?

218

How To Use Our Favorite Guidelines

219

Docetaxel

220

Adjuvant HD Cisplatin-RT For High Risk Head & Neck Cancer

221

Melanoma In A Nutshell

222

Loong TFRs In CML, A Lack Of Agility, & CHEKCMATE 816

223

Ribociclib-Tamoxifen: A Cautionary Tale

224

Relatlimab + Nivo And the VISION trial

225

HOPA Boston Preview

226

DESTINY-Breast03

227

Chemo Toxicity Prediction & Risk

228

Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC)

229

7 + 3

230

Prostate Ca Updates From ASCO GU 22

231

Bacillus Calmette-Guerin

232

KIR, HLA - C, & Rituximab

233

GI Cancer Updates & Tebentafusp

234

Precision Medicine Demystified

235

New Hallmarks Of Cancers & LenPembro For Endometrial Cancer

236

Carfilzomib

237

So, You Want to Work (from home) as a Specialty Pharmacist

238

Drugs of 2021: Keep, Return Or Re-gift?

239

ASH21 The More Things Change...

240

So, You Want to be a Pediatric Oncology Pharmacist

241

Dasatinib Dosing & DREAMseq

242

Sun's Out, T Cells Out

243

So, You Want To Be An MSL Oncology Pharmacist

244

Asciminib

245

Adjuvant Atezo, Palbo-PPI Interaction? And More

246

Decreased Cardiotoxicity With Infusional Doxorubicin

247

Adjuvant Abemaciclib

248

Same Day Pegfilgrastim

249

Sarcomas In A Nutshell

250

ESMO21 & New Drugs (Cervical Ca Focus)

251

CASSIOPEIA Part 2

252

MMF For ITP

253

Hypercalcemia Of Malignancy (in Under 10)

254

Belzutifan and Recent Updates

255

Booster COVID-19 Vaccinations in Immunocompromised Patients

256

Sneaky TKI Toxicities

257

Acala V. Ibrutinib(again) & VidazaAllo

258

Breast Cancer & cGVHD Updates

259

GOG-172 (IP chemotherapy in ovarian cancer)

260

Advertising Amateur Hour

261

Capecitabine

262

Hormonal Toxicity Management In Breast Cancer Pts

263

EA1131 & TOURMALINE

264

Why Learning Oncology Is Hard

265

ASCO 2021

266

Sotorasib, Infigratinib, And More

267

Amivantamab

268

Venetoclax (with Dr. Kayleigh Marx)

269

Dosing In Obesity

270

Dostarlimab, Loncastuximab tesirine, & HER2 GI Updates

271

A Landmark Trial (without an FDA approval)

272

COVID Vaccine (Myeloma & CLL), MANHATTAN And More

273

IO Uh Oh

274

Cancer COVID Vaccine Updates + AMBORO

275

ICIs In Esophageal & GEJ Cancers

276

Emend's Emergence

277

Tivozanib (and More)

278

Indolent Lymphoma Week

279

Melphalan Flufenamide

280

Trilaciclib, Cemiplimab & GU Updates

281

Filgrastim Turns 30

282

Umbralisib

283

Tepotinib

284

Updates on mRCC and COVID-19 Vaccination

285

Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)

286

JBR10

287

Updates from December 2020

288

Trastuzumab

289

Best Of 2020

290

COVID Vaccines In Cancer Patients - What We Don't Know

291

Breast Cancer Updates Dec. 2020

292

Colon Cancer Updates (IDEA & Keynote - 177)

293

CLOT

294

Pembrolizumab for TNBC & CML Updates

295

Ifosfamide

296

BELLINI

297

Updates On Keynote-426, Ph+ ALL, & Post - AlloHSCT Maintenance

298

Monthly Immunotherapy Expanded Approvals Update

299

Fulvestrant's Fumbled Dosing

300

Dexamethasone